Form 8-K - Current report:
SEC Accession No. 0001104659-24-128241
Filing Date
2024-12-13
Accepted
2024-12-13 09:15:53
Documents
16
Period of Report
2024-12-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2430827d1_8k.htm   iXBRL 8-K 30017
6 EXHIBIT 99.1 tm2430827d1_ex99-1.htm EX-99.1 29858
7 GRAPHIC tm2430827d1_ex99-1img001.jpg GRAPHIC 3220
  Complete submission text file 0001104659-24-128241.txt   295875

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bcyc-20241213.xsd EX-101.SCH 3553
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcyc-20241213_def.xml EX-101.DEF 26932
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcyc-20241213_lab.xml EX-101.LAB 36558
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcyc-20241213_pre.xml EX-101.PRE 25556
19 EXTRACTED XBRL INSTANCE DOCUMENT tm2430827d1_8k_htm.xml XML 5653
Mailing Address BLOCKS A & B, PORTWAY BUILDING GRANTA PARK, GREAT ABINGTON CAMBRIDGE X0 CB21 6GS
Business Address BLOCKS A & B, PORTWAY BUILDING GRANTA PARK, GREAT ABINGTON CAMBRIDGE X0 CB21 6GS 011441223261503
BICYCLE THERAPEUTICS PLC (Filer) CIK: 0001761612 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38916 | Film No.: 241546949
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)